...
首页> 外文期刊>Orbit >IgG4-rich reactive lymphoid hyperplasia of the lacrimal gland
【24h】

IgG4-rich reactive lymphoid hyperplasia of the lacrimal gland

机译:幼苗腺体富含IgG4的活性淋巴增生

获取原文
获取原文并翻译 | 示例
           

摘要

We describe an otherwise healthy 24-year-old woman with reactive lymphoid hyperplasia of one lacrimal gland. She was found to have modest elevation of serum IgG4 and high density of IgG4+ plasma cells in her lacrimal gland, ranging from 40% to 60% of IgG+ plasma cells. The patient transiently responded to systemic corticosteroids before treatment with rituximab. IgG4-rich reactive lymphoid hyperplasia of the lacrimal gland is neither an established part of IgG4-related disease spectrum nor a known precursor lesion to lymphoma. Although there is a plausible risk of transforming to IgG4-related disease or to lymphoma, the biological potential and natural history of IgG4-rich reactive lymphoid hyperplasia remains to be determined.
机译:我们描述了一个健康的24岁女性,具有一个泪腺的活性淋巴增生。 发现她在泪腺中具有适度的血清IgG4和IgG4 +浆细胞的高密度,范围为IgG +血浆细胞的40%至60%。 患者在用Rituximab治疗之前瞬时应对全身皮质类固醇。 泪腺的IgG4丰富的反应性淋巴增生既不是IgG4相关疾病谱的建立部分,也不是已知的淋巴瘤的前体病变。 虽然存在与IgG4相关疾病或淋巴瘤转化的可合理风险,但IgG4的活性淋巴增生的生物潜力和自然历史仍有待确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号